Astellas Pharma Inc.
ALPMF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $31 | $17 | $132 | $157 |
| Dep. & Amort. | $199 | $158 | $106 | $80 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$166 | -$87 | -$24 | $6 |
| Other Non-Cash | $131 | $84 | $114 | $15 |
| Operating Cash Flow | $195 | $172 | $328 | $257 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$37 | -$38 | -$89 | -$76 |
| Net Acquisitions | $0 | -$785 | $0 | -$1 |
| Inv. Purchases | $0 | $0 | $0 | -$6 |
| Inv. Sales/Matur. | $13 | $0 | $13 | $6 |
| Other Inv. Act. | -$65 | -$23 | -$9 | $15 |
| Investing Cash Flow | -$89 | -$846 | -$85 | -$62 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$89 | $771 | -$15 | -$60 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$7 | -$11 | -$61 | -$51 |
| Dividends Paid | -$129 | -$117 | -$100 | -$85 |
| Other Fin. Act. | -$37 | -$30 | -$20 | -$20 |
| Financing Cash Flow | -$261 | $614 | -$196 | -$216 |
| Forex Effect | $9 | $18 | $13 | $11 |
| Net Chg. in Cash | -$147 | -$41 | $61 | -$10 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $336 | $377 | $316 | $326 |
| End Cash | $188 | $336 | $377 | $316 |
| Free Cash Flow | $137 | $90 | $239 | $181 |